Evidence map›Paper›PMID 34353323›Full record

ArticleHarm reduction journal2021

A qualitative study on overdose response in the era of COVID-19 and beyond: how to spot someone so they never have to use alone.

Melissa Perri, Natalie Kaminski, Matthew Bonn, Gillian Kolla, Adrian Guta, Ahmed M Bayoumi, Laurel Challacombe, Marilou Gagnon, Natasha Touesnard, Patrick McDougall and 1 more

Abstract read
In one paragraph

Article in Harm reduction journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Opioid-related deaths in Northern Ontario in the early COVID-19 pandemic period.Canadian journal of public health = Revue canadienne de sante publique · 2025
    Article
  14. Predictors of overdose response hotline use for mental health and fatal overdose prevention.Canadian journal of public health = Revue canadienne de sante publique · 2025
    Article
  15. Using illicit drugs alone in Vancouver, Canada: a gender-based analysis.Substance abuse treatment, prevention, and policy · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Melissa PerriDalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Natalie KaminskiDalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Matthew BonnCanadian Association of People Who Use Drugs, Dartmouth, NS, Canada.
Gillian KollaCanadian Institute for Substance Use Research, University of Victoria, Victoria, British Columbia, Canada.
Adrian GutaSchool of Social Work, University of Windsor, Windsor, ON, Canada.
Ahmed M BayoumiMAP Center for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.
Laurel ChallacombeCATIE, Toronto, ON, Canada.
Marilou GagnonCanadian Institute for Substance Use Research, University of Victoria, Victoria, British Columbia, Canada.
Natasha TouesnardCanadian Association of People Who Use Drugs, Dartmouth, NS, Canada.
Patrick McDougallDr. Peter AIDS Foundation, Vancouver, BC, Canada.
Carol StrikeDalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada. carol.strike@utoronto.ca.ORCID 0000-0002-2716-3681

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSpotting is an informal practice among people who use drugs (PWUD) where they witness other people using drugs and respond if an overdose occurs. During COVID-19 restrictions, remote spotting (e.g., using a telephone, video call, and/or a social media app) emerged to address physical distancing requirements and reduced access to harm reduction and/or sexually transmitted blood borne infection (STBBI's) prevention services. We explored spotting implementation issues from the perspectives of spotters and spottees.

methodsResearch assistants with lived/living expertise of drug use used personal networks and word of mouth to recruit PWUD from Ontario and Nova Scotia who provided or used informal spotting. All participants completed a semi-structured, audio-recorded telephone interview about spotting service design, benefits, challenges, and recommendations. Recordings were transcribed and thematic analysis was used.

resultsWe interviewed 20 individuals between 08/2020-11/2020 who were involved in informal spotting. Spotting was provided on various platforms (e.g., telephone, video calls, and through texts) and locations (e.g. home, car), offered connection and community support, and addressed barriers to the use of supervised consumption sites (e.g., location, stigma, confidentiality, safety, availability, COVID-19 related closures). Spotting calls often began with setting an overdose response plan (i.e., when and who to call). Many participants noted that, due to the criminalization of drug use and fear of arrest, they preferred that roommates/friends/family members be called instead of emergency services in case of an overdose. Both spotters and spottees raised concerns about the timeliness of overdose response, particularly in remote and rural settings.

conclusionSpotting is a novel addition to, but not replacement for, existing harm reduction services. To optimize overdose/COVID-19/STBBI's prevention services, additional supports (e.g., changes to Good Samaritan Laws) are needed. The criminalization of drug use may limit uptake of formal spotting services.

Indexed as

CommunicationCOVID-19PandemicsCrimeDrug OverdoseEmergency TreatmentFearHarm ReductionHumansNeedle-Exchange ProgramsNova ScotiaOntarioSocial StigmaSocioeconomic FactorsSubstance-Related DisordersSurveys and QuestionnairesCOVID-19DigitalDigital health interventionsHarm reductionOverdose preventionSpotting

Identifiers

PMID34353323
PMCPMC8339679

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.